Secondary analyses of sex differences in attention improvements across three clinical trials of a digital therapeutic in children, adolescents, and adults with ADHD

Jessica E. Flannery,Stephen P. Hinshaw,Scott H. Kollins,Caitlin A. Stamatis
DOI: https://doi.org/10.1186/s12889-024-18597-5
IF: 4.5
2024-05-01
BMC Public Health
Abstract:Attention-deficit/hyperactivity disorder (ADHD) remains underdiagnosed and undertreated in girls. Inattentive symptoms, often predominant in girls with ADHD, represent a key driver of impairment and often persist into adulthood. AKL-T01 is a regulated digital therapeutic targeting inattention. We examined potential sex differences in the efficacy of AKL-T01 in three separate trials for 1) children, 2) adolescents, and 3) adults.
public, environmental & occupational health
What problem does this paper attempt to address?